The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

Background Despite the high rate of sudden death after myocardial infarction among
patients with a low ejection fraction, implantable cardioverter–defibrillators are …

Ambulatory ECG (AECG) is very commonly employed in a variety of clinical contexts to
detect cardiac arrhythmias and/or arrhythmia patterns which are not readily obtained from …

The possibilities and implementation of wearable cardiac monitoring beyond atrial fibrillation
are increasing continuously. This review focuses on the real-world use and evolution of …

Las guías de práctica clínica (GPC) tienen como objetivo reunir y evaluar toda la evidencia
relevante disponible durante el proceso de elaboración sobre un tema particular para …

More than 40 years after the first implantable cardioverter-defibrillator (ICD) implantation,
sudden cardiac death (SCD) still accounts for more than five million deaths worldwide every …

The advances in the miniaturisation of electronic devices and the deployment of cheaper
and faster data networks have propelled environments augmented with contextual and real …